The Patent Finder

Provid Pharmaceuticals Inc.

Also on record
Records under this name other than the patents Provid Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Provid Pharmaceuticals Inc.

PatentTitleStatus Expires Confidence
US 9,376,4377-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,688,6797-Benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1H)-One, Salts Thereof and Methods of Using the Same in Combination Therapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,265,7657-Benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3h)-one, Salts Thereof and Methods of Using the Same in Combination Therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,845,3247-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, Analogs Thereof, and Salts Thereof and Methods for Their Use in Therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,266,5337-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, Analogs Thereof, and Salts Thereof and Methods for Their Use in Therapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,976,0687-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-a]PYRIDO[3,4-e]PYRIMIDIN-5(1H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,439,231Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof
Term ended
Term ended Sep 29, 2025 · From the USPTO record
Term endedTerm ended Sep 29, 2025From the USPTO record
US 7,432,342Kinase Anchor Protein Muteins, Peptides Thereof, and Related Methods
Formerly held
Term ended
Term ended Sep 16, 2024 · High confidence
Term endedTerm ended Sep 16, 2024High confidence
US 8,222,215Methods for the use of inhibitors of antigen presentation by MHC class II molecules
Lapsed on the fee record
Ended Jul 17, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jul 17, 2024From the USPTO record
US 7,947,645APO E analogs and methods for their use
Formerly held
Lapsed on the fee record
Ended May 24, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 24, 2023From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited